The FWD1/β-TrCP-mediated degradation pathway establishes a 'turning off switch' of a Cdc42 guanine nucleotide exchange factor, FGD1

被引:21
作者
Hayakawa, M
Kitagawa, H
Miyazawa, K
Kitagawa, M
Kikugawa, K
机构
[1] Tokyo Univ Pharm & Life Sci, Sch Pharm, Tokyo 1920392, Japan
[2] Univ Tokyo, Bunkyo Ku, Dept Mol Pathol, Grad Sch Med, Tokyo 1130033, Japan
[3] Hamamatsu Univ Sch Med, Dept Biochem 1, Hamamatsu, Shizuoka 4313192, Japan
关键词
D O I
10.1111/j.1365-2443.2005.00834.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
FWD1/beta-TrCP is the F-box protein that functions as the receptor subunit of the SCFFWD1/beta-TrCP ubiquitin ligase and has been shown to be responsible for the degradation of important signaling molecules such as IkappaBs and beta-catenin. Protein substrates of FWD1/beta-TrCP contain a consensus DSGPsiXS motif (where Psi represents a hydrophobic residue and X represents any amino acid). Recognition by FWD1/beta-TrCP requires phosphorylation of the conserved serines in that motif. Here we show that FGD1, a Cdc42 guanine nucleotide exchange factor (GEF), is a novel target of the SCFFWD1/beta-TrCP ubiquitin ligase. A mutant FGD1 protein, FGD1(SA), in which both of the critical serine residues in the DSGPsiXS motif have been replaced by alanines, does not interact with FWD1/beta-TrCP and exhibits increased stability. Morphological changes induced by wild-type FGD1 (FGD1(WT)) are reduced by the co-expression of SCFFWD1/beta-TrCP whereas those induced by FGD1(SA) are not affected. FGD1(SA)-expressing cells show a higher level of cell motility than FGD1(WT)-expressing cells. We present a novel 'turning off' mechanism for the inactivation of FGD1, an upstream regulator for Cdc42.
引用
收藏
页码:241 / 251
页数:11
相关论文
共 25 条
[1]
Benard V, 2002, METHOD ENZYMOL, V345, P349
[2]
Fgd1, the Cdc42 guanine nucleotide exchange factor responsible for faciogenital dysplasia, is localized to the subcortical actin cytoskeleton and Golgi membrane [J].
Estrada, L ;
Caron, E ;
Gorski, JL .
HUMAN MOLECULAR GENETICS, 2001, 10 (05) :485-495
[3]
Cdc42 regulates GSK-3β and adenomatous polyposis coli to control cell polarity [J].
Etienne-Manneville, S ;
Hall, A .
NATURE, 2003, 421 (6924) :753-756
[4]
ISOLATION OF A NEW HUMAN ONCOGENE FROM A DIFFUSE B-CELL LYMPHOMA [J].
EVA, A ;
AARONSON, SA .
NATURE, 1985, 316 (6025) :273-275
[5]
CATALYSIS OF GUANINE-NUCLEOTIDE EXCHANGE ON THE CDC42HS PROTEIN BY THE DBL ONCOGENE PRODUCT [J].
HART, MJ ;
EVA, A ;
EVANS, T ;
AARONSON, SA ;
CERIONE, RA .
NATURE, 1991, 354 (6351) :311-314
[6]
Spatial sensing in fibroblasts mediated by 3′ phosphoinositides [J].
Haugh, JM ;
Codazzi, F ;
Teruel, M ;
Meyer, T .
JOURNAL OF CELL BIOLOGY, 2000, 151 (06) :1269-1279
[7]
Evidence that reactive oxygen species do not mediate NF-κB activation [J].
Hayakawa, M ;
Miyashita, H ;
Sakamoto, I ;
Kitagawa, M ;
Tanaka, H ;
Yasuda, H ;
Karin, M ;
Kikugawa, K .
EMBO JOURNAL, 2003, 22 (13) :3356-3366
[8]
The ubiquitin system [J].
Hershko, A ;
Ciechanover, A .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :425-479
[9]
Phosphorylation meets ubiquitination:: The control of NF-κB activity [J].
Karin, M ;
Ben-Neriah, Y .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :621-+
[10]
Regulation of the discs large tumor suppressor by a phosphorylation-dependent interaction with the β-TrCP ubiquitin ligase receptor [J].
Mantovani, F ;
Banks, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (43) :42477-42486